Can We Develop a Nonpulsatile Permanent Rotary Blood Pump? Yes, We Can.

For many years, it was thought that nonpulsatile perfusion produced physiological and circulatory abnormalities. Since 1977, Yukihiko Nosé and his colleagues have challenged this misconception. Toward that end, they did show that if a 20% higher blood flow uses more than that required for a pulsatile blood pump, then there would be no circulatory or physiological abnormalities. These experimental findings confirm that there is no difference in clinical outcome using either a pulsatile or nonpulsatile blood pump. Furthermore, the nonpulsatile rotary blood pump demonstrates efficient and reliable performance in various clinical situations. The nonpulsatile blood pump is a simple and reliable design that is manufactured easily and that has several desirable features. There is no need to incorporate heart valves, which are the most thrombogenic and blood trauma-inducing component. A continuous flow pump does not require a large orifice inflow conduit and proves to be easier to implant in patients with minimal damage to the myocardium. There is no need to incorporate a compliance volume-shifting device, which is essential for a pulsatile blood pump. The nonpulsatile device is a continuous blood pumping system; therefore, the control system is simpler and more reliable than that of a pulsatile pump. Because of the rotary blood pump's structure, only one moving part is necessary for the blood-pumping motion. By using durable components for this moving part, a durable system becomes possible. Because the electrical motor operates continuously, the on-and-off motion required for a pulsatile pump is not necessary; therefore, it is a more efficient and durable system. Thus, this group is working on the development of a nonpulsatile blood pump as a permanently implantable assist device. To achieve this goal, it is necessary to incorporate seven features into the system: small size, atraumatic features, antithrombogenic features, antiinfection features, a simple and durable design, and low energy requirement with easy controllability.

[1]  A. Gristina,et al.  Biomaterial-centered infection: microbial adhesion versus tissue integration. , 1987, Science.

[2]  G Damm,et al.  Successful thermal management of a totally implantable ventricular assist system. , 1994, Artificial organs.

[3]  H Harasaki,et al.  Physiopathological studies of nonpulsatile blood flow in chronic models. , 1983, Transactions - American Society for Artificial Internal Organs.

[4]  P M Portner,et al.  Initial clinical experience with a wearable controller for the Novacor left ventricular assist system. , 1994, ASAIO journal.

[5]  H Harasaki,et al.  Comparison of hemodynamic changes in a chronic nonpulsatile biventricular bypass (BVB) and total artificial heart (TAH). , 1980, Transactions - American Society for Artificial Internal Organs.

[6]  Y Nosé,et al.  Development of an axial flow ventricular assist device: in vitro and in vivo evaluation. , 1995, Artificial organs.

[7]  Y Nosé,et al.  The Thirteenth Hastings lecture. My life with the National Institutes of Health Artificial Heart Program. , 1990, Artificial organs.

[8]  H Harasaki,et al.  Use of a centrifugal pump for temporary left ventricular assist system. , 1978, Transactions - American Society for Artificial Internal Organs.

[9]  I. Sakuma,et al.  Development of totally implantable electromechanical artificial heart systems: Baylor ventricular assist system. , 2008, Artificial organs.

[10]  Michael E. DeBakey,et al.  A Simple Continuous-Flow Blood Transfusion Instrument , 1934 .

[11]  Y Nosé,et al.  Is a totally implantable artificial heart realistic? , 2008, Artificial organs.

[12]  Y. Nosé.  Nonpulsatile mode of blood flow required for cardiopulmonary bypass and total body perfusion. , 2008, Artificial organs.

[13]  Y Nosé,et al.  The need for standardizing the index of hemolysis. , 1994, Artificial organs.

[14]  T. Myers,et al.  Use of a left ventricular assist device in an outpatient setting. , 1994, ASAIO journal.

[15]  H Harasaki,et al.  Chronic nonpulsatile blood flow in an alive, awake animal 34-day survival. , 1980, Transactions - American Society for Artificial Internal Organs.

[16]  R Kiraly,et al.  Comparative evaluation of nonpulsatile and pulsatile cardiac prostheses. , 1980, Transactions - American Society for Artificial Internal Organs.

[17]  Y Nosé,et al.  Arterial pressure pulsation during nonpulsatile biventricular bypass experiments: possible idioperipheral pulsation. , 1986, Artificial organs.

[18]  Y Nosé,et al.  The effect of the impeller-driver magnetic coupling distance on hemolysis in a compact centrifugal pump. , 1996, Artificial organs.

[19]  R Kiraly,et al.  Compliance chamber--system integration studies. , 1984, Transactions - American Society for Artificial Internal Organs.

[20]  E F Bernstein,et al.  Prolonged pulsatile and nonpulsatile LV bypass with a centrifugal pump. , 1976, Transactions - American Society for Artificial Internal Organs.

[21]  H. Harasaki,et al.  Idioperipheral pulsation during nonpulsatile biventricular bypass experiments. , 1986, ASAIO transactions.

[22]  E F Bernstein,et al.  Progress in the design of a centrifugal cardiac assist pump with trans-cutaneous energy transmission by magnetic coupling. , 1969, Transactions - American Society for Artificial Internal Organs.

[23]  George P. Noon,et al.  Clinical Use of Cardiac Assist Devices , 1993 .

[24]  Y Nosé,et al.  Is a pulsatile cardiac prosthesis a dying dinosaur? , 1992, Artificial organs.

[25]  H. Harasaki,et al.  Chronic nonpulsatile blood flow. , 1982, Transactions - American Society for Artificial Internal Organs.

[26]  George Damm,et al.  Development of a Pivot Bearing Supported Sealless Centrifugal Pump for Ventricular Assist. , 1996, Artificial organs.

[27]  S Takatani,et al.  Evaluation of the Wear of the Pivot Bearing in the Gyro C1E3 Pump. , 1996, Artificial organs.